nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.377	0.588	CbGbCtD
Ezogabine—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.159	0.249	CbGbCtD
Ezogabine—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.105	0.164	CbGbCtD
Ezogabine—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00752	0.105	CbGeAlD
Ezogabine—KCNQ4—retina—acquired immunodeficiency syndrome	0.00559	0.0779	CbGeAlD
Ezogabine—KCNQ5—retina—acquired immunodeficiency syndrome	0.00543	0.0758	CbGeAlD
Ezogabine—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00432	0.0603	CbGeAlD
Ezogabine—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.0034	0.0474	CbGeAlD
Ezogabine—KCNQ5—vagina—acquired immunodeficiency syndrome	0.00337	0.047	CbGeAlD
Ezogabine—KCNQ5—nervous system—acquired immunodeficiency syndrome	0.00295	0.0412	CbGeAlD
Ezogabine—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.00289	0.0403	CbGeAlD
Ezogabine—KCNQ5—central nervous system—acquired immunodeficiency syndrome	0.00284	0.0396	CbGeAlD
Ezogabine—UGT1A4—blood—acquired immunodeficiency syndrome	0.00275	0.0384	CbGeAlD
Ezogabine—KCNQ3—lung—acquired immunodeficiency syndrome	0.00256	0.0357	CbGeAlD
Ezogabine—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.00242	0.0338	CbGeAlD
Ezogabine—KCNQ3—nervous system—acquired immunodeficiency syndrome	0.00237	0.033	CbGeAlD
Ezogabine—KCNQ4—brain—acquired immunodeficiency syndrome	0.00232	0.0323	CbGeAlD
Ezogabine—KCNQ3—central nervous system—acquired immunodeficiency syndrome	0.00228	0.0318	CbGeAlD
Ezogabine—KCNQ5—brain—acquired immunodeficiency syndrome	0.00226	0.0315	CbGeAlD
Ezogabine—KCNQ5—lymph node—acquired immunodeficiency syndrome	0.00218	0.0304	CbGeAlD
Ezogabine—KCNQ2—nervous system—acquired immunodeficiency syndrome	0.00218	0.0304	CbGeAlD
Ezogabine—KCNQ2—central nervous system—acquired immunodeficiency syndrome	0.0021	0.0293	CbGeAlD
Ezogabine—KCNQ3—brain—acquired immunodeficiency syndrome	0.00181	0.0253	CbGeAlD
Ezogabine—KCNQ2—brain—acquired immunodeficiency syndrome	0.00167	0.0232	CbGeAlD
Ezogabine—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.00166	0.0232	CbGeAlD
Ezogabine—UGT1A1—blood—acquired immunodeficiency syndrome	0.00158	0.0221	CbGeAlD
Ezogabine—CYP2A6—vagina—acquired immunodeficiency syndrome	0.00124	0.0172	CbGeAlD
Ezogabine—CYP2A6—lung—acquired immunodeficiency syndrome	0.00117	0.0163	CbGeAlD
Ezogabine—CYP2A6—brain—acquired immunodeficiency syndrome	0.000827	0.0115	CbGeAlD
Ezogabine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000484	0.00168	CcSEcCtD
Ezogabine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000482	0.00168	CcSEcCtD
Ezogabine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000481	0.00167	CcSEcCtD
Ezogabine—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.00048	0.00167	CcSEcCtD
Ezogabine—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000479	0.00167	CcSEcCtD
Ezogabine—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000479	0.00167	CcSEcCtD
Ezogabine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000479	0.00167	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000479	0.00166	CcSEcCtD
Ezogabine—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000478	0.00166	CcSEcCtD
Ezogabine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000478	0.00166	CcSEcCtD
Ezogabine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000477	0.00166	CcSEcCtD
Ezogabine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000476	0.00166	CcSEcCtD
Ezogabine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000476	0.00166	CcSEcCtD
Ezogabine—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000476	0.00166	CcSEcCtD
Ezogabine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000475	0.00165	CcSEcCtD
Ezogabine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000473	0.00165	CcSEcCtD
Ezogabine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000473	0.00164	CcSEcCtD
Ezogabine—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000472	0.00164	CcSEcCtD
Ezogabine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000472	0.00164	CcSEcCtD
Ezogabine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000471	0.00164	CcSEcCtD
Ezogabine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00047	0.00164	CcSEcCtD
Ezogabine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000469	0.00163	CcSEcCtD
Ezogabine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000469	0.00163	CcSEcCtD
Ezogabine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000466	0.00162	CcSEcCtD
Ezogabine—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000465	0.00162	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000464	0.00161	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000462	0.00161	CcSEcCtD
Ezogabine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000461	0.00161	CcSEcCtD
Ezogabine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000461	0.0016	CcSEcCtD
Ezogabine—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000458	0.00159	CcSEcCtD
Ezogabine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000458	0.00159	CcSEcCtD
Ezogabine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000458	0.00159	CcSEcCtD
Ezogabine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000457	0.00159	CcSEcCtD
Ezogabine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.00159	CcSEcCtD
Ezogabine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.00158	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000455	0.00158	CcSEcCtD
Ezogabine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000455	0.00158	CcSEcCtD
Ezogabine—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.00157	CcSEcCtD
Ezogabine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000452	0.00157	CcSEcCtD
Ezogabine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00045	0.00157	CcSEcCtD
Ezogabine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00045	0.00156	CcSEcCtD
Ezogabine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00045	0.00156	CcSEcCtD
Ezogabine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000449	0.00156	CcSEcCtD
Ezogabine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000449	0.00156	CcSEcCtD
Ezogabine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.00155	CcSEcCtD
Ezogabine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000446	0.00155	CcSEcCtD
Ezogabine—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000445	0.00155	CcSEcCtD
Ezogabine—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.00154	CcSEcCtD
Ezogabine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000442	0.00154	CcSEcCtD
Ezogabine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000442	0.00154	CcSEcCtD
Ezogabine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000441	0.00154	CcSEcCtD
Ezogabine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00044	0.00153	CcSEcCtD
Ezogabine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000435	0.00151	CcSEcCtD
Ezogabine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000433	0.00151	CcSEcCtD
Ezogabine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.0015	CcSEcCtD
Ezogabine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.0015	CcSEcCtD
Ezogabine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00043	0.0015	CcSEcCtD
Ezogabine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.00149	CcSEcCtD
Ezogabine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.00149	CcSEcCtD
Ezogabine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00148	CcSEcCtD
Ezogabine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000426	0.00148	CcSEcCtD
Ezogabine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000426	0.00148	CcSEcCtD
Ezogabine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000426	0.00148	CcSEcCtD
Ezogabine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000426	0.00148	CcSEcCtD
Ezogabine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000425	0.00148	CcSEcCtD
Ezogabine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000424	0.00148	CcSEcCtD
Ezogabine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000424	0.00147	CcSEcCtD
Ezogabine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00147	CcSEcCtD
Ezogabine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000421	0.00147	CcSEcCtD
Ezogabine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000418	0.00146	CcSEcCtD
Ezogabine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000418	0.00145	CcSEcCtD
Ezogabine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000418	0.00145	CcSEcCtD
Ezogabine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000417	0.00145	CcSEcCtD
Ezogabine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000415	0.00144	CcSEcCtD
Ezogabine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000415	0.00144	CcSEcCtD
Ezogabine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000414	0.00144	CcSEcCtD
Ezogabine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000413	0.00144	CcSEcCtD
Ezogabine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000412	0.00143	CcSEcCtD
Ezogabine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.00143	CcSEcCtD
Ezogabine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00041	0.00143	CcSEcCtD
Ezogabine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00142	CcSEcCtD
Ezogabine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00142	CcSEcCtD
Ezogabine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000407	0.00141	CcSEcCtD
Ezogabine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.0014	CcSEcCtD
Ezogabine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000402	0.0014	CcSEcCtD
Ezogabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000402	0.0014	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.0014	CcSEcCtD
Ezogabine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000401	0.0014	CcSEcCtD
Ezogabine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.00139	CcSEcCtD
Ezogabine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.0004	0.00139	CcSEcCtD
Ezogabine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.00139	CcSEcCtD
Ezogabine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.0004	0.00139	CcSEcCtD
Ezogabine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000399	0.00139	CcSEcCtD
Ezogabine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000398	0.00139	CcSEcCtD
Ezogabine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00138	CcSEcCtD
Ezogabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000398	0.00138	CcSEcCtD
Ezogabine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.00138	CcSEcCtD
Ezogabine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.00138	CcSEcCtD
Ezogabine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.00138	CcSEcCtD
Ezogabine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00137	CcSEcCtD
Ezogabine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000394	0.00137	CcSEcCtD
Ezogabine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000391	0.00136	CcSEcCtD
Ezogabine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00039	0.00136	CcSEcCtD
Ezogabine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000389	0.00135	CcSEcCtD
Ezogabine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000389	0.00135	CcSEcCtD
Ezogabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000389	0.00135	CcSEcCtD
Ezogabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000388	0.00135	CcSEcCtD
Ezogabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000386	0.00134	CcSEcCtD
Ezogabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000385	0.00134	CcSEcCtD
Ezogabine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000385	0.00134	CcSEcCtD
Ezogabine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.00134	CcSEcCtD
Ezogabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000385	0.00134	CcSEcCtD
Ezogabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000384	0.00134	CcSEcCtD
Ezogabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000383	0.00133	CcSEcCtD
Ezogabine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000383	0.00133	CcSEcCtD
Ezogabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.00133	CcSEcCtD
Ezogabine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000383	0.00133	CcSEcCtD
Ezogabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.00133	CcSEcCtD
Ezogabine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000381	0.00133	CcSEcCtD
Ezogabine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000381	0.00132	CcSEcCtD
Ezogabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000378	0.00132	CcSEcCtD
Ezogabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00132	CcSEcCtD
Ezogabine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00131	CcSEcCtD
Ezogabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.00131	CcSEcCtD
Ezogabine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000375	0.0013	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000374	0.0013	CcSEcCtD
Ezogabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000373	0.0013	CcSEcCtD
Ezogabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000373	0.0013	CcSEcCtD
Ezogabine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00129	CcSEcCtD
Ezogabine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00128	CcSEcCtD
Ezogabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000367	0.00128	CcSEcCtD
Ezogabine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.00128	CcSEcCtD
Ezogabine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000366	0.00127	CcSEcCtD
Ezogabine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.00127	CcSEcCtD
Ezogabine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000365	0.00127	CcSEcCtD
Ezogabine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.00127	CcSEcCtD
Ezogabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00127	CcSEcCtD
Ezogabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00127	CcSEcCtD
Ezogabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00126	CcSEcCtD
Ezogabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.00126	CcSEcCtD
Ezogabine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00125	CcSEcCtD
Ezogabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000359	0.00125	CcSEcCtD
Ezogabine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000358	0.00124	CcSEcCtD
Ezogabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00124	CcSEcCtD
Ezogabine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00124	CcSEcCtD
Ezogabine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00124	CcSEcCtD
Ezogabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000355	0.00124	CcSEcCtD
Ezogabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00123	CcSEcCtD
Ezogabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00123	CcSEcCtD
Ezogabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000354	0.00123	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00123	CcSEcCtD
Ezogabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00123	CcSEcCtD
Ezogabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00122	CcSEcCtD
Ezogabine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.00122	CcSEcCtD
Ezogabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00122	CcSEcCtD
Ezogabine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00122	CcSEcCtD
Ezogabine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00035	0.00122	CcSEcCtD
Ezogabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000349	0.00121	CcSEcCtD
Ezogabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00121	CcSEcCtD
Ezogabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00121	CcSEcCtD
Ezogabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00121	CcSEcCtD
Ezogabine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.0012	CcSEcCtD
Ezogabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.0012	CcSEcCtD
Ezogabine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000344	0.0012	CcSEcCtD
Ezogabine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.00119	CcSEcCtD
Ezogabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.00119	CcSEcCtD
Ezogabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00119	CcSEcCtD
Ezogabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00119	CcSEcCtD
Ezogabine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00118	CcSEcCtD
Ezogabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000339	0.00118	CcSEcCtD
Ezogabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000338	0.00118	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00117	CcSEcCtD
Ezogabine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00117	CcSEcCtD
Ezogabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00117	CcSEcCtD
Ezogabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00117	CcSEcCtD
Ezogabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00117	CcSEcCtD
Ezogabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00117	CcSEcCtD
Ezogabine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.00116	CcSEcCtD
Ezogabine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000334	0.00116	CcSEcCtD
Ezogabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000334	0.00116	CcSEcCtD
Ezogabine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000332	0.00116	CcSEcCtD
Ezogabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000332	0.00116	CcSEcCtD
Ezogabine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.00115	CcSEcCtD
Ezogabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.00115	CcSEcCtD
Ezogabine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00114	CcSEcCtD
Ezogabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00113	CcSEcCtD
Ezogabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.00113	CcSEcCtD
Ezogabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000325	0.00113	CcSEcCtD
Ezogabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00112	CcSEcCtD
Ezogabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00112	CcSEcCtD
Ezogabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00112	CcSEcCtD
Ezogabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00112	CcSEcCtD
Ezogabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000319	0.00111	CcSEcCtD
Ezogabine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000318	0.00111	CcSEcCtD
Ezogabine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000318	0.00111	CcSEcCtD
Ezogabine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000313	0.00109	CcSEcCtD
Ezogabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.00109	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00109	CcSEcCtD
Ezogabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00108	CcSEcCtD
Ezogabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00108	CcSEcCtD
Ezogabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00108	CcSEcCtD
Ezogabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00108	CcSEcCtD
Ezogabine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00108	CcSEcCtD
Ezogabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00107	CcSEcCtD
Ezogabine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000306	0.00107	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00105	CcSEcCtD
Ezogabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00104	CcSEcCtD
Ezogabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00104	CcSEcCtD
Ezogabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00104	CcSEcCtD
Ezogabine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00104	CcSEcCtD
Ezogabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00103	CcSEcCtD
Ezogabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00103	CcSEcCtD
Ezogabine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.00102	CcSEcCtD
Ezogabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00102	CcSEcCtD
Ezogabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.00102	CcSEcCtD
Ezogabine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00102	CcSEcCtD
Ezogabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.000998	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.000997	CcSEcCtD
Ezogabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000996	CcSEcCtD
Ezogabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000286	0.000995	CcSEcCtD
Ezogabine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.000988	CcSEcCtD
Ezogabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.000976	CcSEcCtD
Ezogabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.000961	CcSEcCtD
Ezogabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.000952	CcSEcCtD
Ezogabine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000949	CcSEcCtD
Ezogabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000273	0.000948	CcSEcCtD
Ezogabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00094	CcSEcCtD
Ezogabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.000903	CcSEcCtD
Ezogabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.0009	CcSEcCtD
Ezogabine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000897	CcSEcCtD
Ezogabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.000896	CcSEcCtD
Ezogabine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000257	0.000894	CcSEcCtD
Ezogabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.000869	CcSEcCtD
Ezogabine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000858	CcSEcCtD
Ezogabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.000857	CcSEcCtD
Ezogabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000845	CcSEcCtD
Ezogabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000832	CcSEcCtD
Ezogabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000829	CcSEcCtD
Ezogabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000808	CcSEcCtD
Ezogabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000801	CcSEcCtD
Ezogabine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000793	CcSEcCtD
Ezogabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000793	CcSEcCtD
Ezogabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000764	CcSEcCtD
Ezogabine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000764	CcSEcCtD
Ezogabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000763	CcSEcCtD
Ezogabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000747	CcSEcCtD
Ezogabine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000728	CcSEcCtD
Ezogabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000728	CcSEcCtD
Ezogabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000719	CcSEcCtD
Ezogabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000686	CcSEcCtD
